Читать книгу Blood and Marrow Transplantation Long Term Management - Группа авторов - Страница 58

The “Recommended screening and preventive practices for long‐term survivors after hematopoietic cell transplantation” represent the basis for the follow‐up program. These recommendations, provided by an international group of transplantation experts, were published for the first time in 2006 [36,37] and updated in 2012 [7,35]. To assure international applicability, the three transplant societies who initiated the project in 2006 (the Center for International Blood and Marrow Transplant Research, EBMT, and the American Society of Blood and Marrow Transplantation), invited transplant societies worldwide (the Asia–Pacific Blood and Marrow Transplantation Group, the Bone Marrow Transplant Society of Australia and New Zealand, the East Mediterranean Blood and Marrow Transplantation Group, and the Sociedada Brasileira de Transpante de Medula Ossea) to participate in the updated recommendations of 2012. In this multi‐published paper, the working group recognized that the models and primary site for long‐term follow‐up might vary by country and available resources. Furthermore, it included some suggestions referring to the setup of a posttransplant survivorship clinic [35]:

 The HSCT recipient should be provided with a survivorship care plan that includes a treatment strategy summary and a follow‐up plan to facilitate the transition from the immediate transplantation care to the long‐term follow‐up care.

 Primary health providers and hemato‐oncologists that will take care of long‐term survivors have to be educated on the unique exposures, risk factors, and medical issues of HSCT long‐term survivors.

 Prevention, screening, and management of late complications of transplantation require a multidisciplinary approach. Therefore, the long‐term follow‐up program has to establish a multidisciplinary team.

The Be The Match / National Marrow Donor Program (NMDP), which is one of the leaders in providing hematopoietic stem cells or umbilical cord blood units to patients for unrelated HSCT, also supports patient care by elaborating material for medical education. The NMDP has recently developed guidelines in consultation with several leading transplant organizations for posttransplant care [38]. These guidelines, intended for healthcare providers who have to follow up transplant survivors, provide recommendations on post‐transplant screening, vaccination, and GVHD.